drugset / Trial / NCT00171119

A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril

NCT00171119

Phase 4 Terminated 81 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of valsartan, benazepril or the combination of both in reduction of microalbuminuria in Type 2 diabetic patients.

Timeline

Start
2004-01
Primary completion
2005-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Valsartan Small molecule